申请人:JACOBIO PHARMACEUTICALS CO., LTD.
公开号:US11136320B2
公开(公告)日:2021-10-05
A compound represented by formula I or a pharmaceutically acceptable salt thereof and a use thereof in preparing a drug for treating, stopping or preventing a disease or disorder mediated by FGFR4 activity.
一种由式 I 代表的化合物或其药学上可接受的盐及其在制备治疗、阻止或预防由 FGFR4 活性介导的疾病或紊乱的药物中的用途。